| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | CESSATION THERAPEUTICS, INC. | 3031 TISCH WAY STE 110 | SAN JOSE | CA | 95128-2561 | SANTA CLARA | USA | U01DA063352 | Development of the anti-fentanyl monoclonal antibody, CSX-1004, for prophylaxis against fentanyl and fentanyl analog overdose | 000 | 1 | NIH | 11/24/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $2,612,736 ) |
| | 2025 | 2025 | CESSATION THERAPEUTICS, INC. | 3031 TISCH WAY STE 110 | SAN JOSE | CA | 95128-2561 | SANTA CLARA | USA | U01DA063352 | Development of the anti-fentanyl monoclonal antibody, CSX-1004, for prophylaxis against fentanyl and fentanyl analog overdose | 000 | 1 | NIH | 9/2/2025 | $2,612,736 |
|
| Issue Date FY: 2024 ( Subtotal = -$714 ) |
| | 2024 | 2021 | CESSATION THERAPEUTICS, INC. | 3031 TISCH WAY STE 110 | SAN JOSE | CA | 95128-2561 | SANTA CLARA | USA | U01DA051071 | Process Development, Manufacturing, and Preclinical Evaluation of a Monoclonal Antibody for Fentanyl Overdose | 000 | 2 | NIH | 10/12/2023 | -$714 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | CESSATION THERAPEUTICS, LLC | 3031 TISCH WAY STE 505 | SAN JOSE | CA | 95128-2531 | SANTA CLARA | USA | U01DA051071 | Process Development, Manufacturing, and Preclinical Evaluation of a Monoclonal Antibody for Fentanyl Overdose | 000 | 2 | NIH | 1/20/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,022,018 ) |
| | 2021 | 2021 | CESSATION THERAPEUTICS, LLC | 3031 TISCH WAY STE 505 | SAN JOSE | CA | 95128-2531 | SANTA CLARA | USA | U01DA051071 | Process Development, Manufacturing, and Preclinical Evaluation of a Monoclonal Antibody for Fentanyl Overdose | 001 | 2 | NIH | 8/27/2021 | $1,022,571 |
| | 2021 | 2020 | CESSATION THERAPEUTICS, LLC | 3031 TISCH WAY STE 505 | SAN JOSE | CA | 95128-2531 | SANTA CLARA | USA | U01DA051071 | Process Development, Manufacturing, and Preclinical Evaluation of a Monoclonal Antibody for Fentanyl Overdose | 000 | 1 | NIH | 3/15/2021 | $0 |
| | 2021 | 2019 | CESSATION THERAPEUTICS, LLC | 3031 TISCH WAY STE 505 | SAN JOSE | CA | 95128-2531 | SANTA CLARA | USA | R43DA048720 | Development of Therapeutic Anti-Nicotine Monoclonal Antibodies through Trivalent Vaccine Design | 000 | 1 | NIH | 8/9/2021 | -$553 |
|
| Issue Date FY: 2020 ( Subtotal = $6,107,502 ) |
| | 2020 | 2020 | CESSATION THERAPEUTICS, LLC | 3031 TISCH WAY STE 505 | SAN JOSE | CA | 95128-2531 | SANTA CLARA | USA | U01DA051071 | Process Development, Manufacturing, and Preclinical Evaluation of a Monoclonal Antibody for Fentanyl Overdose | 000 | 1 | NIH | 9/25/2020 | $6,107,502 |
|
| Issue Date FY: 2019 ( Subtotal = $211,174 ) |
| | 2019 | 2019 | CESSATION THERAPEUTICS, LLC | 3031 TISCH WAY STE 505 | SAN JOSE | CA | 95128-2531 | SANTA CLARA | USA | R43DA048720 | Development of Therapeutic Anti-Nicotine Monoclonal Antibodies through Trivalent Vaccine Design | 000 | 1 | NIH | 5/24/2019 | $211,174 |
|
|
